Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6526
    +0.0026 (+0.40%)
     
  • OIL

    83.07
    +0.26 (+0.31%)
     
  • GOLD

    2,338.10
    -0.30 (-0.01%)
     
  • Bitcoin AUD

    98,112.70
    -4,264.54 (-4.17%)
     
  • CMC Crypto 200

    1,332.45
    -50.12 (-3.63%)
     
  • AUD/EUR

    0.6083
    +0.0012 (+0.20%)
     
  • AUD/NZD

    1.0947
    +0.0005 (+0.04%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,077.05
    +36.67 (+0.46%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,015.20
    -73.50 (-0.41%)
     
  • Hang Seng

    17,268.24
    +66.97 (+0.39%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why Shares of BioNTech Rose Friday

Why Shares of BioNTech Rose Friday

Shares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical trial for its non-small cell lung cancer therapy candidate. The company focuses on immunotherapies to treat cancer, infectious diseases, and other diseases. BioNTech's shares have been sliding because sales of Comirnaty, the COVID-19 vaccine it developed with Pfizer, are falling.